Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY38.30 CNY
Change Today -0.41 / -1.06%
Volume 3.7M
002287 On Other Exchanges
As of 3:00 AM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

tibet cheezheng tibetan-a (002287) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/12/15 - CNY51.00
52 Week Low
07/2/14 - CNY20.22
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TIBET CHEEZHENG TIBETAN-A (002287)

Related News

No related news articles were found.

tibet cheezheng tibetan-a (002287) Related Businessweek News

No Related Businessweek News Found

tibet cheezheng tibetan-a (002287) Details

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicine in China and internationally. The company provides drug products in the areas of cardiovascular, respiratory, digestive, urinary and reproductive system, nervous system, musculoskeletal system, gynecological disorders, and other fields. Its products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment, and Tiebangchui Zhitong plaster, as well as oral medicine series. The company offers its medicines in the foam of emplastrum, ointments, granules, pills, and powders. Tibet Cheezheng Tibetan Medicine Co. Ltd. was founded in 1995 and is based in Nyingchi, China.

Founded in 1995

tibet cheezheng tibetan-a (002287) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tibet cheezheng tibetan-a (002287) Key Developments

Tibet Cheezheng Tibetan Medicine Co. Ltd. Recommends Amendments to the Articles of Association

Tibet Cheezheng Tibetan Medicine Co. Ltd. at its EGM to be held on July 1, 2015, will recommend amendments to the articles of association of the company.

Tibet Cheezheng Tibetan Medicine Co. Ltd. Declares Final Cash Dividend for 2014, Payable on June 17, 2015

Tibet Cheezheng Tibetan Medicine Co. Ltd. declared a cash dividend of CNY 3.890 per ten shares (tax included) under 2014 final distribution plan to be implemented (A shares). The dividend is payable on June 17, 2015 to the shareholders of record date on June 16, 2015. The ex-date is June 17, 2015.

Tibet Cheezheng Tibetan Medicine Co. Ltd. Approves Cash Dividend for the Year 2014

Tibet Cheezheng Tibetan Medicine Co. Ltd. announced that at the annual general meeting held on 19 May 2015, approved cash dividend per 10 shares (tax included) of CNY 3.89000000 for the year 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002287:CH CNY38.30 CNY -0.41

002287 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
JinZangHuang Tibet Pharmaceuticals Inc $0.0071 USD -0.0041
View Industry Companies

Industry Analysis


Industry Average

Valuation 002287 Industry Range
Price/Earnings 63.2x
Price/Sales 15.7x
Price/Book 9.8x
Price/Cash Flow 64.5x
TEV/Sales 15.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIBET CHEEZHENG TIBETAN-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at